Integra Lifesciences Holdings Corp
General ticker "IART" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $1.8B
Integra Lifesciences Holdings Corp does not follow the US Stock Market performance with the rate: -31.9%.
Estimated limits based on current volatility of 2.1%: low 21.49$, high 22.43$
Factors to consider:
- US accounted for 71.4% of revenue in the fiscal year ended 2023-12-31
- Current price 35.0% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [33.88$, 50.36$]
- 2024-12-30 to 2025-12-30 estimated range: [39.52$, 56.76$]
Financial Metrics affecting the IART estimates:
- Positive: Non-GAAP EPS, $ of 3.10 > 2.29
- Positive: 1.03 < Operating profit margin, % of 7.23
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 1.76
Short-term IART quotes
Long-term IART plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1,542.45MM | $1,557.67MM | $1,541.57MM |
| Operating Expenses | $1,345.22MM | $1,318.75MM | $1,430.05MM |
| Operating Income | $197.23MM | $238.92MM | $111.53MM |
| Non-Operating Income | $17.45MM | $-25.03MM | $-30.46MM |
| Interest Expense | $50.40MM | $49.59MM | $51.38MM |
| R&D Expense | $93.05MM | $101.19MM | $174.59MM |
| Income(Loss) | $214.68MM | $213.89MM | $81.07MM |
| Taxes | $45.60MM | $33.34MM | $13.33MM |
| Profit(Loss) | $169.07MM | $180.55MM | $67.74MM |
| Stockholders Equity | $1,684.80MM | $1,804.40MM | $1,587.88MM |
| Inventory | $317.39MM | $324.58MM | $389.61MM |
| Assets | $3,782.38MM | $3,889.76MM | $3,781.99MM |
| Operating Cash Flow | $312.43MM | $264.47MM | $139.96MM |
| Capital expenditure | $48.08MM | $47.09MM | $66.86MM |
| Investing Cash Flow | $-161.44MM | $-58.58MM | $-94.18MM |
| Financing Cash Flow | $-98.23MM | $-251.95MM | $-229.93MM |
| Earnings Per Share* | $2.00 | $2.18 | $0.87 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.